P

Pfizer

Makes cancer drugs, vaccines and other medicines

Field Medical Director - Breast and Gynecological Cancers, MD

Full-TimePosted on 10/21/2026
$230.9k - $384.8k/yr
Mid, Senior
MD
Kansas, USA+3 moreMore locations: Nebraska, USA | Missouri, USA | Illinois, USA
Remote
Biology & Biotech
No H1B Sponsorship

About the job

Requirements
  • An MD or equivalent is required.
  • Relevant experience is required: MD with 4 years, PhD or PharmD with 5 years, MBA or MS with 7 years, or BA/BSc with 8 years.
  • Demonstrated subject-matter expertise recognized across internal and external stakeholders.
  • Breadth of diverse leadership experiences and capabilities, including influencing and collaborating with peers to create business impact.
  • Demonstrated clinical and technical skills.
  • Excellent oral and written communication skills.
  • Interpersonal skills to understand and respond to multiple external and internal customer demands and manage conflict constructively.
  • Change agility, flexibility for new opportunities such as new therapeutic areas, and adaptability to organizational change.
  • Ability to manage a significant volume of projects developed in a remote environment, prioritize and implement them successfully, exercise sound judgment, and work in a continuous-improvement environment.
  • Ability to work within a matrixed, multidisciplinary team and foster strong professional relationships with Pfizer customers aligned with Pfizer Medical objectives.
  • Ability to manage and lead change in an evolving external health care environment.
  • Ability to problem-solve and network across the enterprise to identify solutions.
  • Ability to collaborate effectively and demonstrate leadership and teamwork with peers, internal stakeholders, and external customers to build alignment and partnership around a shared vision or strategy.
  • Ability to be self-starting and accountable, with urgency in delivering results that have medical impact and provide a positive customer experience.
  • Ability to maintain self-awareness and choose behaviors and responses based on their impact on personal and others’ performance and engagement.
  • Ability to rapidly adopt new digital technology, including artificial intelligence, and use new technologies in routine work and with medical customers.
  • Document all medical interactions as required in a timely manner.
  • Ability to operate a company car and regularly travel by air for HCP/customer meetings, medical congresses, and internal company meetings; proximity to an airline hub city is required.
  • Ability to travel 50–75% of the time.
  • Permanent work authorization in the United States is required.
  • Ability to work weekends for congress coverage.
Responsibilities
  • Plan and execute medical strategy and engagement for appropriate assigned customers within a territory, coordinating compliantly with Pfizer colleagues as needed to achieve medical objectives.
  • Maintain required knowledge of relevant therapeutic areas, disease states, and Pfizer medicines, and provide therapeutic-area and product information to internal and external stakeholders as needed.
  • Serve as a conduit and resource for Medical Information and customer insights, provide requested information to healthcare professionals as allowed by Pfizer guidance, and share customer viewpoints with Pfizer as appropriate.
  • Understand Pfizer Medical Affairs priorities to contribute to medical content strategy development and execute aligned field medical tactics.
  • Maintain effective and appropriate communication and collaboration among headquarters Medical colleagues, Medical Information, and other Pfizer Field Medical colleagues.
  • Communicate across multiple channels, including live and virtual presentations in small or large settings, written communications, and telephone or virtual conversations.
  • Optimize patient centricity in medical communications and deliverables by incorporating health literacy and cultural-awareness principles.
  • Deliver approved medical content about Pfizer medicines and relevant topics in the designated therapeutic area.
  • Identify and seek medical engagement with priority customer segments in the assigned therapeutic area.
  • Provide truthful, accurate, scientifically supported information in response to direct unsolicited medical requests from healthcare professionals in compliance with applicable Pfizer guidelines, policies, and procedures.
  • Manage and provide scientific leadership in a regional territory, collaborating with cross-therapeutic-area field medical colleagues in shared institutions.
  • Contribute to or co-lead virtual advisory boards with manager oversight as appropriate.
  • Field relevant inbound queries from healthcare professionals through the established triage process.
  • Partner with Global Medical Affairs, Oncology Research & Development, and Clinical Operations to identify potential sites for Pfizer-sponsored clinical trials, including sites serving under-represented patient populations.
  • Provide appropriate medical support throughout the Investigator Sponsored Research process.
  • Cultivate research and therapeutic-area expertise, including familiarity with the latest congress data and disease-state literature.
  • Provide asset leadership as needed.
  • Understand study design, methodology, data analysis, and interpretation principles and communicate these concepts to customers.
  • Communicate reactively and proactively with local patient advocacy groups, as appropriate, in close collaboration with Corporate Affairs and headquarters Medical Affairs.
  • Deliver insights on local patient-organization structure, capabilities, and patient-population needs.
  • Serve on Medical and/or therapeutic-area and asset cross-functional committees as appropriate.
  • Represent Pfizer Medical Affairs leadership with clinical and professional associations and societies, demonstrating medical professionalism in all interactions.
  • Provide mentorship as an onboarding partner and mentor for advisory boards and study leads as appropriate.
  • Participate in special projects as needed.
  • Collaborate compliantly with commercial colleagues to support practitioner needs.
Desired Qualifications
  • Previous Field Medical experience.
  • Breast Cancer therapeutic-area expertise.
  • Gynecological Cancers therapeutic-area expertise.
  • Residing in or near Chicago, Illinois.
  • Familiarity with internal and external standard operating procedures, rules, and regulations regarding Pfizer/customer interactions and relationships.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.

Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.